Related Experiment Video

Updated: Jun 21, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Are beta-blockers useful in the prevention of osteoporotic fractures?

J L Pérez-Castrillón1, D A De Luis, A Duenas-Laita

  • 1Internal Medicine Department, Rio Hortega University Hospital, Faculty of Medicine, Valladolid, Spain. castrv@terra.es

European Review for Medical and Pharmacological Sciences
|August 14, 2009
PubMed

Insights

Beta-blockers, used for cardiovascular conditions, may also prevent osteoporotic fractures. Research suggests they counteract bone loss caused by the sympathetic nervous system, potentially benefiting patients with both atherosclerosis and osteoporosis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Gerontology

Background:

  • Atherosclerosis and osteoporosis are prevalent chronic diseases affecting similar aging populations.
  • Therapeutic strategies addressing both conditions simultaneously could improve patient compliance.
  • Beta-blockers are established treatments for hypertension, ischemic heart disease, and heart failure, reducing cardiovascular mortality.

Purpose of the Study:

  • To review existing data on the role of beta-blockers in bone metabolism.
  • To evaluate the potential of beta-blockers in preventing osteoporotic fractures.
  • To explore their relevance in patients with co-existing cardiovascular disease and osteoporosis.

Main Methods:

  • Review of experimental data on sympathetic nervous system effects on bone.
  • Analysis of retrospective case-control and cohort studies investigating beta-blocker use and fracture risk.
  • Synthesis of evidence regarding beta-blocker mechanisms and clinical outcomes.

Main Results:

  • Experimental studies indicate sympathetic nervous system activation inhibits bone formation and increases resorption.
  • Beta-blocker administration has been shown to counteract these negative effects on bone.
  • Observational studies suggest a potential benefit of beta-blockers in reducing fracture risk, though findings are not entirely consistent.

Conclusions:

  • Beta-blockers may play a role in preventing osteoporotic fractures by modulating sympathetic nervous system activity.
  • Further research is warranted to confirm the protective effect of beta-blockers against fractures in at-risk populations.
  • This could represent a dual-action therapeutic approach for patients with cardiovascular disease and osteoporosis.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.